Itou, M., Kawaguchi, T., Taniguchi, E., Oriishi, T., & Sata, M. (2012). Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report. S. Karger AG.
Chicago Style CitationItou, Minoru, Takumi Kawaguchi, Eitaro Taniguchi, Tetsuharu Oriishi, i Michio Sata. Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report. S. Karger AG, 2012.
Cita MLAItou, Minoru, et al. Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report. S. Karger AG, 2012.
Atenció: Aquestes cites poden no estar 100% correctes.